Clinical Trial Update: Supplementation With Omega-3: Mechanism of Action [Phase 2]

View source ↗

Summary

Phase 2 study exploring the mechanism of action of omega-3 fatty acid supplementation for hypertriglyceridemia. The trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Johns Hopkins University | Conditions: Hypertriglyceridemia | Phase 2 | Status: TERMINATED